Original Research

Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States

Bogart M, Bengtson LG, Johnson MG, Bunner SH, Gronroos NN, DiRocco KK

International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:97-110

Published Date: 11 January 2024